Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,475,256
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
4,407,729
-
Shares change
-
+101,419
-
Total reported value, excl. options
-
$29,090,550
-
Value change
-
+$1,257,765
-
Put/Call ratio
-
3.94%
-
Number of buys
-
29
-
Number of sells
-
-15
-
Price
-
$6.6
Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q4 2022
63 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q4 2022.
AVITA Medical, Inc. - Common Stock (RCEL) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,407,729 shares
of 26,475,256 outstanding shares and own 16.65% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1,148,326 shares), PURA VIDA INVESTMENTS, LLC (934,233 shares), BlackRock Inc. (475,802 shares), MILLENNIUM MANAGEMENT LLC (311,161 shares), GEODE CAPITAL MANAGEMENT, LLC (252,756 shares), RENAISSANCE TECHNOLOGIES LLC (216,312 shares), AMERIPRISE FINANCIAL INC (147,952 shares), DIMENSIONAL FUND ADVISORS LP (84,015 shares), STATE STREET CORP (83,645 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (75,609 shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.